Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: Results from a randomized phase II trial
Modern Rheumatology. 2015 Sep 10:1-9. [Epub ahead of print]
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Modern Rheumatology. 2015 Sep 10:1-9. [Epub ahead of print]
Arthritis Rheumatol. 2015 May 4. doi: 10.1002/art.39183. [Epub ahead of print]
Arthritis Res Ther. 2015 May 20;17(1):135. [Epub ahead of print]
Frontiers in Immunology. 2015;6:151. doi:10.3389/fimmu.2015.00151
Arthritis Rheumatol. Vol. 67, No. 6, June 2015, pp 1424–1437
Arthritis Rheumatol. 2015;67(1):117–127
Arthritis Rheumatol. 2015;67(1):51–62
Arthritis Care Res (Hoboken). 2014 Sep 3. doi: 10.1002/acr.22453. [Epub ahead of print]
Arthritis Rheumatol. 2014;66(11):2924–2937
Arthritis Research and Therapy 2014,16:R102